Top 5 Life Science Angel Investors in France in November 2024
A list of 5 angel investors that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.Top 5 Life Science Angel Investors in France in November 2024
Investor | Life Science France investments |
---|---|
Bernard Majoie | 1 |
Bertrand Jacquelot | 1 |
Andrew Nutter | 1 |
Xavier Niel | 1 |
Sebastian Lombardo | 1 |
Bernard Majoie - President @ Fournier-Majoie
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more
Investment focus
- E-Commerce, Information Technology, Food and Beverage
- Pre-Seed, Seed, Angel
- France, United States
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Pre-Seed, Funding Round
- France, United Kingdom, United States
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Funding Round
- France, United States, United Kingdom
Portfolio highlights
- CUBE AI — Cube AI boosts back-office logistics efficiency, allowing teams to handle more loads and focus on human relationships.
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- The Mobile-First Company — Early Stage Startup that is Simplifying Business, One App at a Time. Forget about those overcomplicated, pricey software giants. We're building easy, mobile-first tools that actually make sense.
Sebastian Lombardo - CEO @ Valtech
Show more
Investment focus
- Apps, Internet, Lifestyle
- Seed
- France, United States
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Investors by industry
Health Care
Google
Gaming
Climate
Energy
Community
Marketplace
Hardware
Biotech
Consumer
Proptech
Artificial intelligence
FinTech
Impact
EdTech
Sustainability
Venture Capital
Fashion
Big Data
Finance
Web3
B2B
Beauty
Retail
Education
Clean Energy
Oil and Gas
Food and Beverage
Real Estate
Video Games
Payments
Infrastructure
Photography
Financial Services
Organic Food
Publishing
Social Media
Social Network
Wellness
Enterprise Software
Medical
Android
Digital Media
Music
Legal
Franchise
Local
Internet
Construction
Sports
eSports
Manufacturing
Email
Mobile
Art
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Platforms
Cannabis
Mobile Advertising
Medical Device
Automotive
Wine And Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Theatre
Film
Life Science
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
India
Canada
South Korea
Australia
Ireland
New Zealand
United States
Africa
Vietnam
Saudi Arabia
Japan
South Africa
Europe
Oceania
LATAM
Indonesia
Middle East
Asia
Sri Lanka
China
Singapore
Brazil
Armenia
Qatar
Spain
Chile
Belgium
France
Belarus
Egypt
Ghana
Croatia
Ethiopia
Costa Rica
Gibraltar
Greece
Finland
Belize
Kenya
Lithuania
Liechtenstein
Panama
Denmark
Myanmar
Lebanon
Cayman Islands
Mexico
Philippines
Mali
Norway
Malta
Israel
Italy
Kazakhstan
Cambodia
Peru
Kuwait
Malaysia
Nicaragua
Liberia
Mauritius
Morocco
Jersey
Slovenia
Thailand
Uzbekistan
Serbia
Hong Kong
Zimbabwe
Sierra Leone
Zambia
Venezuela
Taiwan
Togo
Portugal
Turkey
Seychelles
San Marino
Uganda
Rwanda
Uruguay
Ukraine
Sweden
Senegal
Tanzania
Tunisia
Russian Federation
El Salvador
Poland
Puerto Rico
Tajikistan
Dominican Republic
Barbados
Bahrain
Iraq
Bahamas
Azerbaijan
Nigeria
Iceland
Namibia
United Arab Emirates
Hungary
Honduras
Georgia
Bolivia
Isle of Man
Bermuda
Luxembourg
Czech Republic
Ecuador
Bulgaria
Pakistan
Albania
Algeria
Estonia
Faroe Islands
Colombia
Argentina
Jordan
Bangladesh
Grenada
Romania
Oman
Cyprus
Latvia
Cameroon
Austria
Switzerland
Guatemala
Marshall Islands
Angel Investors in France by industry
Crowdfunding
Venture Capital
Fitness
Restaurants
Cryptocurrency
Finance
Video Games
Organic Food
Wine And Spirits
Photography
Education
Wellness
Medical Device
Email
Social Media
Internet
Social Network
Manufacturing
Digital Media
Art
Android
Mobile
Blockchain
Legal
Construction
Software
Sports
Enterprise Software
Hospitality
Travel
Music
InsurTech
Recruiting
Platforms
Biotechnology
FinTech
Health Care
Consumer
Enterprise
EdTech
Energy
Sustainability
Proptech
SaaS
Marketplace
Hardware
Community
Mobile Apps
Retail
Infrastructure
Fashion
Beauty
Web3
B2B
Food and Beverage
Payments
Financial Services
Impact
Artificial intelligence
Real Estate
Publishing
Big Data
Gaming
Medical
Life Science
Transportation
Media (entertainment)
Agriculture (agtech)
Renewable Energy
Automotive
Biotech
Climate